APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zonisamide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Zonisamide Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchZonisamide Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Zonisamide Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Zonisamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zonisamide Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Zonisamide Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Zonisamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Zonisamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Zonisamide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zonisamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Zonisamide include APOTEX, Bluepharma, Concordia, Glenmark, Intas Pharmaceuticals, Invagen Pharmaceuticals, Wockhardt, Zydus Pharmaceuticals and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Zonisamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Zonisamide market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Zonisamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Zonisamide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Zonisamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Zonisamide Market by Company

APOTEX

Bluepharma

Concordia

Glenmark

Intas Pharmaceuticals

Invagen Pharmaceuticals

Wockhardt

Zydus Pharmaceuticals

Mylan

Sun Pharma

Teva

Eisai

Zonisamide Segment by Type

25mg

50mg

100mg

Zonisamide Segment by Application

Adult

Pediatric

Geriatric

Zonisamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zonisamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zonisamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zonisamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Zonisamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Zonisamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 25mg Table 2. Major Company of 50mg Table 3. Major Company of 100mg Table 4. Global Zonisamide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Zonisamide Sales by Type (2021-2026) & (W Units) Table 6. Global Zonisamide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Zonisamide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Zonisamide Sales Market Share in Value by Type (2021-2026) Table 9. Global Zonisamide Price by Type (2021-2026) & (US$/Unit) Table 10. Global Zonisamide Sales by Type (2027-2032) & (W Units) Table 11. Global Zonisamide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Zonisamide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Zonisamide Sales Market Share in Value by Type (2027-2032) Table 14. Global Zonisamide Price by Type (2027-2032) & (US$/Unit) Table 15. North America Zonisamide Sales by Type (2021-2026) & (W Units) Table 16. North America Zonisamide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Zonisamide Sales by Type (2021-2026) & (W Units) Table 18. Europe Zonisamide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Zonisamide Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Zonisamide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Zonisamide Sales by Type (2021-2026) & (W Units) Table 22. Latin America Zonisamide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Zonisamide Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Zonisamide Sales by Type (2021-2026) & (US$ Million) Table 25. Zonisamide Industry Trends Table 26. Zonisamide Industry Drivers Table 27. Zonisamide Industry Opportunities and Challenges Table 28. Zonisamide Industry Restraints Table 29. Global Zonisamide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Zonisamide Revenue Market Share by Company (2021-2026) Table 31. Global Zonisamide Sales by Company (2021-2026) & (W Units) Table 32. Global Zonisamide Sales Share by Company (2021-2026) Table 33. Global Zonisamide Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Zonisamide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Zonisamide Major Company Production Sites and Headquarters Table 36. Global Zonisamide Company, Product Type & Application Table 37. Global Zonisamide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Zonisamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Zonisamide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Zonisamide Sales by Region (2021-2026) & (W Units) Table 42. Global Zonisamide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Zonisamide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Zonisamide Sales Market Share in Value by Region (2021-2026) Table 45. Global Zonisamide Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Zonisamide Sales by Region (2027-2032) & (W Units) Table 47. Global Zonisamide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Zonisamide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Zonisamide Sales Market Share in Value by Region (2027-2032) Table 50. Global Zonisamide Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Zonisamide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Zonisamide Sales by Application (2021-2026) & (W Units) Table 53. Global Zonisamide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Zonisamide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Zonisamide Sales Market Share in Value by Application (2021-2026) Table 56. Global Zonisamide Price by Application (2021-2026) & (US$/Unit) Table 57. Global Zonisamide Sales by Application (2027-2032) & (W Units) Table 58. Global Zonisamide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Zonisamide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Zonisamide Sales Market Share in Value by Application (2027-2032) Table 61. Global Zonisamide Price by Application (2027-2032) & (US$/Unit) Table 62. North America Zonisamide Sales by Application (2021-2026) & (W Units) Table 63. North America Zonisamide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Zonisamide Sales by Application (2021-2026) & (W Units) Table 65. Europe Zonisamide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Zonisamide Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Zonisamide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Zonisamide Sales by Application (2021-2026) & (W Units) Table 69. Latin America Zonisamide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Zonisamide Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Zonisamide Sales by Application (2021-2026) & (US$ Million) Table 72. APOTEX Company Information Table 73. APOTEX Business Overview Table 74. APOTEX Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. APOTEX Zonisamide Product Portfolio Table 76. APOTEX Recent Development Table 77. Bluepharma Company Information Table 78. Bluepharma Business Overview Table 79. Bluepharma Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bluepharma Zonisamide Product Portfolio Table 81. Bluepharma Recent Development Table 82. Concordia Company Information Table 83. Concordia Business Overview Table 84. Concordia Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Concordia Zonisamide Product Portfolio Table 86. Concordia Recent Development Table 87. Glenmark Company Information Table 88. Glenmark Business Overview Table 89. Glenmark Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Glenmark Zonisamide Product Portfolio Table 91. Glenmark Recent Development Table 92. Intas Pharmaceuticals Company Information Table 93. Intas Pharmaceuticals Business Overview Table 94. Intas Pharmaceuticals Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Intas Pharmaceuticals Zonisamide Product Portfolio Table 96. Intas Pharmaceuticals Recent Development Table 97. Invagen Pharmaceuticals Company Information Table 98. Invagen Pharmaceuticals Business Overview Table 99. Invagen Pharmaceuticals Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Invagen Pharmaceuticals Zonisamide Product Portfolio Table 101. Invagen Pharmaceuticals Recent Development Table 102. Wockhardt Company Information Table 103. Wockhardt Business Overview Table 104. Wockhardt Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Wockhardt Zonisamide Product Portfolio Table 106. Wockhardt Recent Development Table 107. Zydus Pharmaceuticals Company Information Table 108. Zydus Pharmaceuticals Business Overview Table 109. Zydus Pharmaceuticals Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Zydus Pharmaceuticals Zonisamide Product Portfolio Table 111. Zydus Pharmaceuticals Recent Development Table 112. Mylan Company Information Table 113. Mylan Business Overview Table 114. Mylan Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Mylan Zonisamide Product Portfolio Table 116. Mylan Recent Development Table 117. Sun Pharma Company Information Table 118. Sun Pharma Business Overview Table 119. Sun Pharma Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Sun Pharma Zonisamide Product Portfolio Table 121. Sun Pharma Recent Development Table 122. Teva Company Information Table 123. Teva Business Overview Table 124. Teva Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Teva Zonisamide Product Portfolio Table 126. Teva Recent Development Table 127. Eisai Company Information Table 128. Eisai Business Overview Table 129. Eisai Zonisamide Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Eisai Zonisamide Product Portfolio Table 131. Eisai Recent Development Table 132. North America Zonisamide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. North America Zonisamide Sales by Country (2021-2026) & (W Units) Table 134. North America Zonisamide Sales Market Share by Country (2021-2026) Table 135. North America Zonisamide Sales Forecast by Country (2027-2032) & (W Units) Table 136. North America Zonisamide Sales Market Share Forecast by Country (2027-2032) Table 137. North America Zonisamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Zonisamide Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Zonisamide Market Share by Country (2021-2026) Table 140. North America Zonisamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Zonisamide Market Share Forecast by Country (2027-2032) Table 142. Europe Zonisamide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Europe Zonisamide Sales by Country (2021-2026) & (W Units) Table 144. Europe Zonisamide Sales Market Share by Country (2021-2026) Table 145. Europe Zonisamide Sales Forecast by Country (2027-2032) & (W Units) Table 146. Europe Zonisamide Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Zonisamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Zonisamide Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Zonisamide Market Share by Country (2021-2026) Table 150. Europe Zonisamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Zonisamide Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Zonisamide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Zonisamide Sales by Country (2021-2026) & (W Units) Table 154. Asia-Pacific Zonisamide Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Zonisamide Sales Forecast by Country (2027-2032) & (W Units) Table 156. Asia-Pacific Zonisamide Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Zonisamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Zonisamide Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Zonisamide Market Share by Country (2021-2026) Table 160. Asia-Pacific Zonisamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Zonisamide Market Share Forecast by Country (2027-2032) Table 162. Latin America Zonisamide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Latin America Zonisamide Sales by Country (2021-2026) & (W Units) Table 164. Latin America Zonisamide Sales Market Share by Country (2021-2026) Table 165. Latin America Zonisamide Sales Forecast by Country (2027-2032) & (W Units) Table 166. Latin America Zonisamide Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Zonisamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Zonisamide Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Zonisamide Market Share by Country (2021-2026) Table 170. Latin America Zonisamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Zonisamide Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Zonisamide Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Zonisamide Sales by Country (2021-2026) & (W Units) Table 174. Middle East and Africa Zonisamide Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Zonisamide Sales Forecast by Country (2027-2032) & (W Units) Table 176. Middle East and Africa Zonisamide Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Zonisamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Zonisamide Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Zonisamide Market Share by Country (2021-2026) Table 180. Middle East and Africa Zonisamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Zonisamide Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Zonisamide Distributors List Table 185. Zonisamide Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Zonisamide Image Figure 2. Global Zonisamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zonisamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Zonisamide Sales (2021-2032) & (W Units) Figure 5. 25mg Image Figure 6. Global 25mg Sales YoY Growth (2021-2032) & (W Units) Figure 7. 50mg Image Figure 8. Global 50mg Sales YoY Growth (2021-2032) & (W Units) Figure 9. 100mg Image Figure 10. Global 100mg Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Zonisamide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Zonisamide Market Share by Type 2025 VS 2032 Figure 13. North America Zonisamide Sales Market Share in Volume by Type in 2025 Figure 14. North America Zonisamide Sales Market Share in Value by Type in 2025 Figure 15. Europe Zonisamide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Zonisamide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Zonisamide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Zonisamide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Zonisamide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Zonisamide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Zonisamide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Zonisamide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Zonisamide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 27. Pediatric Image Figure 28. Global Pediatric Sales YoY Growth (2021-2032) & (W Units) Figure 29. Geriatric Image Figure 30. Global Geriatric Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Zonisamide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Zonisamide Market Share by Application 2025 VS 2032 Figure 33. North America Zonisamide Sales Market Share in Volume by Application in 2025 Figure 34. North America Zonisamide Sales Market Share in Value by Application in 2025 Figure 35. Europe Zonisamide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Zonisamide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Zonisamide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Zonisamide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Zonisamide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Zonisamide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Zonisamide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Zonisamide Sales Market Share in Value by Application in 2025 Figure 43. North America Zonisamide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Zonisamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Zonisamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Zonisamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Zonisamide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Zonisamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Zonisamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Zonisamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Zonisamide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Zonisamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Zonisamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Zonisamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Zonisamide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Zonisamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Zonisamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Zonisamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Zonisamide Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Zonisamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Zonisamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Zonisamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Zonisamide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Zonisamide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg
  • 50mg
  • 100mg
Applications
  • Adult
  • Pediatric
  • Geriatric
Companies covered
  • APOTEX
  • Bluepharma
  • Concordia
  • Glenmark
  • Intas Pharmaceuticals
  • Invagen Pharmaceuticals
  • Wockhardt
  • Zydus Pharmaceuticals
  • Mylan
  • Sun Pharma
  • Teva
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zonisamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Zonisamide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Zonisamide Market by Type
  6. 1.3.1 25mg
  7. 1.3.2 50mg
  8. 1.3.3 100mg
  9. 1.4 Global Zonisamide Market Size by Type
  10. 1.4.1 Global Zonisamide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Zonisamide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Zonisamide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Zonisamide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Zonisamide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Zonisamide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Zonisamide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Zonisamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Zonisamide Industry Trends
  2. 2.2 Zonisamide Industry Drivers
  3. 2.3 Zonisamide Industry Opportunities and Challenges
  4. 2.4 Zonisamide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Zonisamide Revenue (2021-2026)
  2. 3.2 Global Top Players by Zonisamide Sales (2021-2026)
  3. 3.3 Global Top Players by Zonisamide Price (2021-2026)
  4. 3.4 Global Zonisamide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Zonisamide Major Company Production Sites & Headquarters
  6. 3.6 Global Zonisamide Company, Product Type & Application
  7. 3.7 Global Zonisamide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Zonisamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Zonisamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Zonisamide Tier 1, Tier 2, and Tier 3
4 Zonisamide Regional Status and Outlook
  1. 4.1 Global Zonisamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Zonisamide Historic Market Size by Region
  3. 4.2.1 Global Zonisamide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Zonisamide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Zonisamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Zonisamide Forecasted Market Size by Region
  7. 4.3.1 Global Zonisamide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Zonisamide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Zonisamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Zonisamide by Application
  1. 5.1 Zonisamide Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Pediatric
  4. 5.1.3 Geriatric
  5. 5.2 Global Zonisamide Market Size by Application
  6. 5.2.1 Global Zonisamide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Zonisamide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Zonisamide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Zonisamide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Zonisamide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Zonisamide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Zonisamide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Zonisamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 APOTEX
  2. 6.1.1 APOTEX Company Information
  3. 6.1.2 APOTEX Business Overview
  4. 6.1.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 APOTEX Zonisamide Product Portfolio
  6. 6.1.5 APOTEX Recent Developments
  7. 6.2 Bluepharma
  8. 6.2.1 Bluepharma Company Information
  9. 6.2.2 Bluepharma Business Overview
  10. 6.2.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bluepharma Zonisamide Product Portfolio
  12. 6.2.5 Bluepharma Recent Developments
  13. 6.3 Concordia
  14. 6.3.1 Concordia Company Information
  15. 6.3.2 Concordia Business Overview
  16. 6.3.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Concordia Zonisamide Product Portfolio
  18. 6.3.5 Concordia Recent Developments
  19. 6.4 Glenmark
  20. 6.4.1 Glenmark Company Information
  21. 6.4.2 Glenmark Business Overview
  22. 6.4.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glenmark Zonisamide Product Portfolio
  24. 6.4.5 Glenmark Recent Developments
  25. 6.5 Intas Pharmaceuticals
  26. 6.5.1 Intas Pharmaceuticals Company Information
  27. 6.5.2 Intas Pharmaceuticals Business Overview
  28. 6.5.3 Intas Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Intas Pharmaceuticals Zonisamide Product Portfolio
  30. 6.5.5 Intas Pharmaceuticals Recent Developments
  31. 6.6 Invagen Pharmaceuticals
  32. 6.6.1 Invagen Pharmaceuticals Company Information
  33. 6.6.2 Invagen Pharmaceuticals Business Overview
  34. 6.6.3 Invagen Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Invagen Pharmaceuticals Zonisamide Product Portfolio
  36. 6.6.5 Invagen Pharmaceuticals Recent Developments
  37. 6.7 Wockhardt
  38. 6.7.1 Wockhardt Company Information
  39. 6.7.2 Wockhardt Business Overview
  40. 6.7.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Wockhardt Zonisamide Product Portfolio
  42. 6.7.5 Wockhardt Recent Developments
  43. 6.8 Zydus Pharmaceuticals
  44. 6.8.1 Zydus Pharmaceuticals Company Information
  45. 6.8.2 Zydus Pharmaceuticals Business Overview
  46. 6.8.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Pharmaceuticals Zonisamide Product Portfolio
  48. 6.8.5 Zydus Pharmaceuticals Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Zonisamide Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Sun Pharma
  56. 6.10.1 Sun Pharma Company Information
  57. 6.10.2 Sun Pharma Business Overview
  58. 6.10.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sun Pharma Zonisamide Product Portfolio
  60. 6.10.5 Sun Pharma Recent Developments
  61. 6.11 Teva
  62. 6.11.1 Teva Company Information
  63. 6.11.2 Teva Business Overview
  64. 6.11.3 Teva Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Teva Zonisamide Product Portfolio
  66. 6.11.5 Teva Recent Developments
  67. 6.12 Eisai
  68. 6.12.1 Eisai Company Information
  69. 6.12.2 Eisai Business Overview
  70. 6.12.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Eisai Zonisamide Product Portfolio
  72. 6.12.5 Eisai Recent Developments
7 North America by Country
  1. 7.1 North America Zonisamide Sales by Country
  2. 7.1.1 North America Zonisamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Zonisamide Sales by Country (2021-2026)
  4. 7.1.3 North America Zonisamide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Zonisamide Market Size by Country
  6. 7.2.1 North America Zonisamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Zonisamide Market Size by Country (2021-2026)
  8. 7.2.3 North America Zonisamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Zonisamide Sales by Country
  2. 8.1.1 Europe Zonisamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Zonisamide Sales by Country (2021-2026)
  4. 8.1.3 Europe Zonisamide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Zonisamide Market Size by Country
  6. 8.2.1 Europe Zonisamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Zonisamide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Zonisamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Zonisamide Sales by Country
  2. 9.1.1 Asia-Pacific Zonisamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Zonisamide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Zonisamide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Zonisamide Market Size by Country
  6. 9.2.1 Asia-Pacific Zonisamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Zonisamide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Zonisamide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Zonisamide Sales by Country
  2. 10.1.1 South America Zonisamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Zonisamide Sales by Country (2021-2026)
  4. 10.1.3 South America Zonisamide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Zonisamide Market Size by Country
  6. 10.2.1 South America Zonisamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Zonisamide Market Size by Country (2021-2026)
  8. 10.2.3 South America Zonisamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Zonisamide Sales by Country
  2. 11.1.1 Middle East and Africa Zonisamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Zonisamide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Zonisamide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Zonisamide Market Size by Country
  6. 11.2.1 Middle East and Africa Zonisamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Zonisamide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Zonisamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Zonisamide Value Chain Analysis
  2. 12.1.1 Zonisamide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Zonisamide Production Mode & Process
  7. 12.2 Zonisamide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Zonisamide Distributors
  10. 12.2.3 Zonisamide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst